Why Is Compass Pathways Stock Trading Lower On Monday?

benzinga.com/news/health-care/25/06/46056104/why-is-compass-pathways-stock-trading-lower-on-monday

Compass Pathways plc (NASDAQ:CMPS) released data from the Phase 3 COMP005 trial, the first of two Phase 3 trials evaluating COMP360 for treatment-resistant depression (TRD).
The ongoing COMP005 trial is a randomized, double-blind, placebo-controlled study, which has dosed 258…

This story appeared on benzinga.com, 2025-06-23 15:48:17.
The Entire Business World on a Single Page. Free to Use →